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Calvatia lilacina (CL), Pleurotus ostreatus (PO) and Volvariella volvacea (VV) are widely distributed worldwide and commonly
eatenasmushrooms.Inthisstudy, cellviabilitieswereevaluatedforahumancolorectaladenocarcinomacellline(SW480cells)and
a human monocytic leukemia cell line (THP-1 cells). Apoptotic mechanisms induced by the protein extracts of PO and VV were
evaluated for SW480 cells. The viabilities of THP-1 and SW480 cells decreased in a concentration-dependent manner after 24h of
treatment with the protein extracts of CL, PO or VV. Apoptosis analysis revealed that the percentage of SW480 cells in the SubG1
phase (a marker of apoptosis) was increased upon PO and VV protein-extract treatments, indicating that oligonucleosomalDNA
fragmentation existed concomitantly with cellular death. The PO and VV protein extracts induced reactive oxygen species (ROS)
production, glutathione (GSH) depletion and mitochondrial transmembrane potential (ΔΨm) loss in SW480 cells. Pretreatment
with N-acetylcysteine, GSH or cyclosporine A partially prevented the apoptosis induced by PO protein extracts, but not that
induced by VV extracts, in SW480 cells. The protein extracts of CL, PO and VV exhibited therapeutic eﬃcacy against human
colorectal adenocarcinoma cells and human monocytic leukemia cells. The PO protein extracts induced apoptosis in SW480
cells partially through ROS production, GSH depletion and mitochondrial dysfunction. Therefore, the protein extracts of these
mushroomscould be considered an important source of new anti-cancer drugs.
1.Introduction
Calvatia lilacina (CL), Pleurotus ostreatus (PO) and Volva-
riella volvacea (VV) are three common medicinal or edible
mushrooms. Among them, CL was widely used by CAM
practitionersinChinaandTaiwan fortreatment oftraumatic
bleeding, hemorrhagic vomiting, nasal bleeding, throat and
nasopharyngeal pain, loss ofvoice and coughing. PO showed
antimicrobial and antineoplastic activities [1]. Our previous
study demonstrated that the protein extracts of CL induce
apoptosis through glutathione (GSH) depletion in human
colorectal cancer SW480 cells [2]. The extraction of PO
suppresses the proliferation of breast and colon cancer cells
via p53-dependent and p53-independent pathways [3]. The
water-soluble polysaccharide of PO is capable of enhancing
concanavalin A- or lipopolysaccharide-induced lymphocyte
proliferation [4, 5] and induces apoptosis in human PC-3
androgen-independent cancer cells as well as human HT-
29 colon cancer cells [6, 7]. DNA isolated from the fruit
body of PO augmented NK cytotoxic activity in vitro and
signiﬁcantly increased thelife span ofmice with solid Ehrlich
carcinoma [8]. Despite the observation of anti-cancer eﬀects
for PO, the eﬀects of the protein extract of PO on cancer
are unclear thus far; moreover, there have been no anti-
cancerstudiesonVVproteinextracts. Theanti-cancereﬀects
of the protein extracts of PO and VV are worth studying.
Colorectal cancer and leukemia are two common cancers
in human. The aim of this study was to evaluate the anti-
cancer eﬀects of three protein extracts from CL, PO and
VV on human colorectal cancer SW480 cells and monocytic2 Evidence-Based Complementary and Alternative Medicine
leukemia THP-1 cells. The relationship between apoptosis
and intracellular oxidative stress in cancer cells treated with
PO and VV protein extracts was also evaluated.
2.Methods
2.1. Experimental Material. CL was collected from the
National Chiayi University, Chiayi, Taiwan, in May 2008. PO
and VV were bought from Carrefour Supermarket, Chiayi,
Taiwan, in June 2008.
2.2. Extraction and Isolation of Proteins. CL, PO and VV
(400–450g) were washed twice with distilled water and then
homogenized in cold extraction buﬀer (50mM KH2PO4,
150mM NaCl and 1mM EDTA, pH 7.3) at maximum
speed in a Waring blender for 10min. The water-soluble
protein extract homogenate was ﬁltered through two layers
of surgical gauze, and the ﬁltrate was centrifuged at 8900g
for 20min. The supernatants were precipitated by addition
of ammonium sulphate to 80% saturation, incubated at
4◦C overnight, and then centrifuged at 8900g for 30min.
The protein pellets were resuspended in a phosphate buﬀer
solution (123mM NaCl, 10.4mM Na2HPO4 and 3.16mM
KH2PO4, pH 7.3) (weight/volume = 1:1) and centrifuged.
The supernatants were dialyzed against a 50-fold volume of
phosphate buﬀer solution three times at 4◦Ca n dc l a r i ﬁ e d
by centrifugation. The supernatants were ﬁltered through
0.45μm Millex ﬁlter units (Millipore) and concentrated
using Amicon Ultra-4 (10kDa cut-oﬀ, Millipore) tubes
at 4000g for 20min. The 1mL concentrate was sterilized
using 0.22μm Millex ﬁlter units (Millipore) in a laminar
ﬂow chamber; it was then freeze-dried to obtain a powder
and stored at −80
◦C as stock. The Bio-Rad protein assay
reagent (Bio-Rad Lab., Hercules, CA), 12% sodium dodecyl
sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
and Coomassie Brilliant Blue staining were utilized for the
detection of CL, PO and VV proteins.
2.3. Cell Lines and Reagents. The human colorectal cancer
cell line SW480 and the monocytic leukemia cell line THP-1
were obtained from the Bioresource Collection and Research
Center (Hsinchu, Taiwan, ROC). Dulbecco’s modiﬁed Ea-
gle’smedium(DMEM),RPMI-1640andfoetalbovineserum
(FBS)were obtained from Hyclone(SouthLogan, UT, USA).
Chloromethylﬂourescein diacetate (CMF-DA) was acquired
from Invitrogen Corporation (Carlsbad, CA, USA). Propi-
dium iodide (PI), N-acetylcysteine (NAC), GSH, cyclo-
sporine A (CyA), 2 ,7 -dichlorodihydroﬂuorescein-diacetate
(DCFH-DA), rhodamine 123, 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT), DNase-free
RNase A and other chemicals were purchased from Sigma
Chemical Co. (St. Louis, MO, USA).
2.4. Cell Culture and Treatment. SW480 and THP-1 cells
were cultured in DMEM and RPMI-1640 medium, respec-
tively, containing 10% FBS. The stock solutions of CL, PO
and VV were dissolved in the phosphate buﬀer saline (PBS)
(136.89mM NaCl, 2.68mM KCl, 10.14mM Na2HPO4 and
1.76mM KH2PO4,p H7 . 4 ) ,a n dd i ﬀerent concentrations
(μgmL −1) were prepared in DMEM or RPMI-1640 media.
2.5. Cell Viability Assays. Cell viability was evaluated using
the MTT assay. Yellow MTT was reduced to purple formazan
by dehydrogenases in the mitochondria of living cells. A
solubilization agent, such as dimethyl sulfoxide (DMSO) or
SDS, was used to dissolve the insoluble purple formazan
product into a colored solution. The absorbance of this
colored solution was quantiﬁed at a certain wavelength (usu-
ally 570nm) with a spectrophotometer. The eﬀectiveness of
the protein extracts in causing cell death was evaluated by
comparing the amount of purple formazan produced by
cells treated with the extracts to that produced by untreated
cells. Cells (1 × 106) were cultured in 60mm tissue-culture
dishes for24h. The culture mediumwas replaced with a new
mediumandthecellswereexposedtovariousconcentrations
ofCL,POorVVfor24h.Aftertheindicatedtreatments,cells
were incubated for 2h with 0.5mgmL−1 ofMTT reagentand
then lysed with DMSO. Absorbance was measured at 570nm
in a microplate reader (Bio-Rad, Richmond, CA, USA).
2.6. Cell Cycle and DNA Damage Analysis. The cell cycle
and DNA damage were evaluated with PI staining and
ﬂow cytometry. PI is a speciﬁc ﬂuorescent dye that stains
the double-stranded DNA. In methanol-ﬁxed cells, the PI
molecules translocate into the nucleus and bind to the
double-stranded DNA. Using ﬂow cytometry, PI was excited
at 488nm and emitted ﬂuorescence at 580 ∼ 630nm. The
G1 and G2/M phases are represented by the diploid and
the tetraploid regions, respectively, of the DNA distribution
histograms. Cells in the S phase were found between the
diploid and the tetraploid regions. The length of double-
stranded DNA in cells with DNA damage was smaller than
that of cells in the G1 phase. Fewer PI molecules were found
in DNA-damaged cells as compared with the G1 phase;
the ﬂuorescent intensity of PI in DNA-damaged cells was
weaker than that of cells in the G1 phase. The percentage
of DNA-damaged cells was characterized as the percentage
of cells in the SubG1 region of the DNA distribution
histograms. Cells (1 × 106) were cultured in 60-mm tissue-
culture dishes for 24h. The culture medium was replaced
by a new medium, and then cells were exposed or not to
various concentrations of the protein extracts of PO and
VV for 24h. After treatment, adherent and ﬂoating cells
were pooled, washed with PBS, ﬁxed in PBS-methanol (1:2,
volume/volume) solution, and then maintained at 4◦Cf o r
at least 18h. After one wash with PBS, the cell pellets
were stained with a ﬂuorescent probe solution containing
PBS, 50μgmL −1 PI and 50μgmL −1 DNase-free RNase A
for 30min at room temperature in the dark. The DNA
ﬂuorescence of PI-stained cells was analyzed by excitation at
488nm and monitored through a 630/22nm band-pass ﬁlter
usingaBecton-DickinsonFACScanﬂowcytometer(Franklin
Lakes, NJ, USA). A minimum of 10000 cells was counted
per sample, and the DNA histograms were evaluated further
using Modﬁt software on a PC workstation to calculate the
percentage of cells in various phases of the cell cycle.Evidence-Based Complementary and Alternative Medicine 3
2.7. Measurement of Intracellular Reactive Oxygen Species by
Flow Cytometry. Production of intracellular Reactive oxygen
species (ROS) was detected by ﬂow cytometry using DCFH-
DA. DCFH-DA is a ROS probe that undergoes intracellular
deacetylation to DCFH by esterase in cytosol, followed by
ROS-mediated oxidation to a DCF ﬂuorescent species that is
excited at 485nm and emits ﬂuorescence at 530nm. DCFH-
DA can be used to measure ROS generation in the cyto-
plasm and in cellular organelles such as the mitochondria.
Fluorescence intensity is quantiﬁed using ﬂow cytometry or
a microplate spectrophotometer. After treatment, cells were
treatedwith20μMDCFH-DAfor30mininthedark,washed
once with PBS, detached by trypsinization, collected by
centrifugation and suspended in PBS. The intracellular ROS
levels, as indicated by the ﬂuorescence of dichloroﬂuorescein
(DCF), were measured with a Becton-Dickinson FACScan
ﬂow cytometer.
2.8. Measurement of GSH Depletion. The intracellular GSH
levels were evaluated using CMF-DA. After treatment, the
cells were incubated with 25μMC M F - D Af o r2 0 m i na t
37
◦Ci naC O 2 incubator. Once CMF-DA is internalized
into the cell, cytosolic esterase cleaves the acetates, and the
chloromethyl group reacts with intracellular thiols, altering
the probe into a cell-impermeable ﬂuorescent dye-thioether
adduct, CMF. The CMF ﬂuorescence is directly associated
with intracellular GSH level. After CMF-DA staining, the
cells were washed with PBS, collected by centrifugation and
then ﬂuorescence was measured with a Becton-Dickinson
FACSan ﬂow cytometer.
2.9. Measurement of ΔΨm by Flow Cytometry. After treat-
ment, the cells were trypsinized and then incubated with
5μM rhodamine 123 for 30min at 37◦Ci naC O 2 incubator.
Rhodamine 123, a lipophilic cation, is speciﬁcally and
selectively internalized into the mitochondria of mammalian
cells. The collection of rhodamine 123 is dependent on the
protongradient producedacross mitochondrial membranes.
The accumulation of rhodamine 123 within cells can thus be
used as an indicator of mitochondrial membrane potential
and mitochondrial function. Following the incubation step,
ΔΨm, as indicated by the change in the ﬂuorescence level
of rhodamine 123, was analyzed using a Becton-Dickinson
FACScan ﬂow cytometer.
2.10. Statistical Analysis. Data are presented as means ±
SD from at least three independent experiments and were
analyzed using Student’s t-test. P<. 05 was considered as
statistically signiﬁcant [9].
3.Results
3.1. The Number of Major Proteins and Their Molecular
Weights Were Evaluated in the Protein Extracts of CL, PO
and VV. To detect the number of major proteins and their
molecular weights in the protein extracts of CL, PO and VV,
12% SDS-PAGE gel electrophoresis and Coomassie Brilliant
Blue staining were used. The proﬁles of protein extracts
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Figure 1: Protein extract analysis for CL, VV and PO. Concen-
trations of proteins in extracts of CL, VV and PO were quantiﬁed
with Bio-Rad protein assay reagent. BSA was used as a standard for
protein analysis. Protein extracts (36 and 48μg) of CL, VV and PO
were subjected to SDS-PAGE (12% (w/v) polyacrylamide). CL, VV
andPOproteinextracts were stainedwithCoomassieBrilliantBlue.
Thepositionsofmolecularmassmarkers(inkilodaltons)areshown
on the left and on the right.
from CL, PO and VV used in this study are presented in
Figure 1. Major proteins with various molecular weights
around 70, 55, 45, 40, 28, 24, 20, 18 and 11kDa were
visualized after Coomassie Brilliant Blue staining in 36 and
48μg of protein extracts of CL. Major proteins with various
molecular weights around 175, 96, 95, 72, 68, 32, 23 and
11kDa were visualized in 36 and 48μg of protein extracts of
VV. Major proteins with various molecular weights around
170, 130, 95, 72, 43, 42, 28, 20 and 11kDa were visualized in
36 and 48μg of protein extracts of PO.
3.2. CL, PO and VV Decreased the Viabilities of THP-1 and
SW480 Cells. To evaluate the eﬀects of protein extracts of
CL, PO and VV on the cell viability of human monocytic
leukemia THP-1 cells and human colorectal SW480 cells, a
concentration of 500μgmL −1 was used for the MTT assay.
As indicated in Figure 2(a), the viability of THP-1 cells was
52%, 3% and 3% after 24 h of treatment with CL, PO and
VV, respectively. As indicated in Figure 2(b), the viability of
SW480 cells was 48%, 2% and 7% after 24h of treatment
with CL, PO and VV, respectively. These results suggest that
the degree of cell viability decrease observed for PO and VV
was larger than that for CL in THP-1 and SW480 cells. We
further selected PO and VV for evaluation of the eﬀects of
lower concentrations on the cell viability of SW480 cells.
As indicated in Figure 2(c), the cell viability decreased to
39% after a 24-h treatment with 10 and 25μgmL −1 of PO
proteinextracts.The cellviabilityfurtherdecreasedto10and
7% after treatment with 50 and 100μgmL −1 of PO protein
extracts, respectively. Similarly tothedecreaseincellviability
induced by the PO protein extracts, the protein extracts of
VV also decreased the viability of SW480 cells. As shown
in Figure 2(d),t r e a t m e n tw i t h1 0 μgmL −1 of VV protein4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Cell viability analysis of CL, PO and VV protein extract-treated THP-1 and SW480 cells. (a) THP-1 and (b) SW480 cells were
treated with CL, PO and VV protein extracts (500μgmL −1) for 24h. SW480 cells were treated with 0, 10, 25, 50 and 100μgmL −1 of (c) PO
and (d) VV protein extracts for 24h. After treatment, cell viabilities were evaluated using the MTT assay.The values shownare the means ±
SD (n = 5–8). ∗P<. 05 (signiﬁcantdiﬀerences from the untreated group).
extractsdecreasedcellviabilityby20%;however,thedecrease
in cell viability was less than 10% after treatment with 25, 50
and 100μgmL −1 of VV protein extracts.
3.3. PO and VV Induced DNA Damage in SW480 Cancer
Cells. The DNA damage (SubG1) induced by CL protein
extracts in SW480 cells was reported in our previous study
[2]. The DNA damage induced by PO and VV protein-
extract treatments in SW480 cells has not been extensively
studied. We therefore evaluated whether the protein extracts
of PO and VV could induce apoptosis. SW480 cells were
exposed to100μgmL −1 ofPO andVV for24h, and theDNA
damage of the cells was evaluated by ﬂow cytometry. The
total cells were separated into a damaged DNA group (cells
in the SubG1 phase) and a normal cell cycle group (G1,S
and G2/M phases). As shown in Figure 3, 59.0% untreated
cells were in G1, 29.1% in S, 11.9% in G2/M and 1.9% in
SubG1. The proportion of cells in SubG1 increased to 28.2%
after treatment of SW480 cells with 100μgmL −1 PO protein
extracts for 24h. Following treatment with the protein
extracts of VV (100μgmL −1) for24h, the proportion ofcells
in SubG1 markedly increased to 97.8% in SW480 cells.
3.4. PO and VV Induced ROS in SW480 Cells. ROS are
known to be important mediators of apoptosis and are
induced by various stimuli, including many drugs. For this
reason, intracellular ROS production was measured using a
DCFﬂuorescenceassay following treatment with PO and VVEvidence-Based Complementary and Alternative Medicine 5
0
200
400
600
800
1000
C
e
l
l
n
u
m
b
e
r
02 0 4 0 6 0 8 0
DNA content
Untreated
G0/G1: 59%
G2/M: 11.9%
S: 29.1%
SubG1:1 . 9 %
(a)
0
200
400
600
800
1000
C
e
l
l
n
u
m
b
e
r
02 0 4 0 6 0 8 0
DNA content
PO
G0/G1: 46.7%
G2/M: 15.9%
S: 37.4%
SubG1: 28.2%
(b)
0
200
400
600
800
1000
C
e
l
l
n
u
m
b
e
r
0 20 40 60 80 100 120
DNA content
VV
G0/G1:3 . 8 %
G2/M: 8.8%
S: 87.4%
SubG1: 97.8%
(c)
Figure3:DNAdamageanalysisofPOandVVproteinextract-treated SW480cells.SW480cellsweretreated withPOandVVproteinextracts
(100μgmL −1) for 24h. After treatment, cells were ﬁxed and then stained with propidium iodide, followed by ﬂow cytometric analysis.Data
in each panel show the percentages of cells in SubG1 (DNA-damaged cells), G1,Sa n dG 2/M phases of the cell cycle. These experiments were
performed at least three times and a representative experiment is presented.
protein extracts. As indicated in Figure 4, SW480 cells were
exposed to PO and VV protein extracts at 100μgmL −1 of
for 24h. The DCF ﬂuorescence increased signiﬁcantly from
128.47±736to555.01±9.6and311.61±6.1aftertreatment
with PO and VV protein extracts, respectively.
3.5. PO and VV Induced GSH Depletion in SW480 Cells.
GSH plays an important role in protection against oxidative
stress-induced injury. Intracellular GSH depletion results in
apoptosis. We therefore analyzed changes in the intracellular
GSH level of SW480 cells after treatment with the protein
extractsofPOandVV; weutilizedﬂowcytometricanalysisof
CMF-DAﬂuorescence.SW480cellsweretreatedwithprotein
extracts of PO and VV at 100μgmL −1 for 24h. As shown
in Figure 5, the fractions of cells with intracellular GSH
depletion signiﬁcantly increased to 59.11 ± 4.3 and 99.58 ±
0.4% after treatment with the proteinextracts of PO and VV,
respectively, as compared with untreated cells (0.34 ± 0.2%).
3.6. PO and VV Disrupted ΔΨm in the SW480 Cells.
Mitochondrial dysfunction usually triggers speciﬁc cellular
signaling to induce apoptosis. Loss of ΔΨm is commonly
used to measure mitochondrial dysfunction. To evaluate the
eﬀectsof the protein extracts of PO and VV on ΔΨm, SW480
cells were exposed to the protein extracts of PO and VV at
100μgmL −1 for 24h. The ΔΨm was detected by staining of
rhodamine 123, which speciﬁcally accumulated within the
mitochondrial compartment in a ΔΨm-dependent manner.
As indicated in Figure 6, rhodamine 123 ﬂuorescence was
signiﬁcantly decreased to 153 ± 3a n d4 1± 2 after treatment
with the protein extracts of PO and VV, respectively, as
compared with untreated cells (514 ± 10).
3.7. Evaluation of the Critical Pathway of Apoptosis Induced
by PO and VV. To evaluate the critical pathway of apoptosis
induced by the protein extracts of PO and VV, an extract
concentration of 10μgmL −1 was used. As shown in Figure 7,
16.9% and 18.5% of cells were apoptotic (SubG1 phase) after
treatment with the protein extracts of PO and VV for 24h
as compared with 2.3% and 2.9% of untreated cells, respec-
tively. To evaluate the critical pathway, several agents were
employed: (i)NAC,an intracellular GSH synthetic agent;(ii)
GSH, were used to discover the GSH depletion pathway; and
(iii) CyA, a mitochondrial permeability transition opening
inhibitor, was used to determine the pathway involved in
decreased ΔΨm. SW480 cells were treated with these agents
for 1 h before the addition of the protein extracts of PO and
VV. As shown in Figure 7(a),N A Ca n dG S Hi n h i b i t e dP O
protein extract-induced apoptosis; the fractions of apoptotic
cells decreased to 6.6 and 8.2%, respectively. CyA displayed a
moderate inhibitory eﬀect;the fraction ofapoptoticcells was
11.7%.Figure 7(b)showsthattheapoptoticeﬀectinducedby
the protein extracts of VV was not prevented by NAC, GSH
or CyA; the fractions of apoptotic cells were 19.3, 20.8 and
20.0%, respectively.
4.Discussion
Currently, the prevalent choices for treating human cancer
are surgical resection, general chemotherapy, gene therapy
and radiation therapy. These treatments are costly and
almost always performed in the hospital. It is necessary
to develop new therapeutic strategies, such as integrative
and complementary medicine, for cancer treatment. One
approach, as highlighted in this study, looks for eﬀective
adjuvant substances from edible or medical mushrooms that
are capable of activating the cellular apoptotic response in
cancer cells [10]. Many edible and culinary mushrooms have
become important medicinal and biotechnological species.
For example, Antrodia camphorata, a unique mushroom
of Taiwan, has been used as a traditional medicine for
the prevention of various health-related conditions. It
c a nb ec o n s i d e r e da ne ﬃcient alternative phytotherapeutic
agent or a synergizer for the treatment of cancer [11].
4,7-dimethoxy-5-methyl-l,3-benzodioxole isolated from the
fruiting body of Antrodia camphorata inhibits anchorage-
independent proliferation and G0/G1 cell-cycle regulation6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Intracellular ROS evaluation of PO and VV protein extract-treated SW480 cells. SW480 cells were exposed to PO and VV
protein extracts (100μgmL −1) for 24h. Production of intracellular ROS was detected by ﬂow cytometry using DCFH-DA. The intracellular
ﬂuorescence of DCF was measured with a Becton-Dickinson FACScan ﬂow cytometer. Data in each panel represent the DCF ﬂuorescence
intensity within the cells. The values shown are the means ± SD (n = 5–8 of individual experiments). ∗P<. 05 (signiﬁcant diﬀerences from
the untreated group).
in human colorectal carcinoma cells [12]. Another study
reported that the basidiomycete mushroom Agaricus blazei
Murrill, a mushroom native to Brazil, is traditionally used
to treat many common diseases, such as atherosclerosis,
hepatitis, hyperlipidemia, diabetes, dermatitis and cancer
[13]. Agaricus blazei extract, which increases apoptosis via
ROS-dependent JNK activation and inhibition of constitu-
tive NF-κB in leukemia THP-1 cells [14], has been reported
to have anti-tumor and anti-mutagenic eﬀects [15]. The
water-extract of Chaga mushroom (Inonotus obliquus)h a s
potent inhibitory eﬀects on B16-F10 melanoma that include
anti-proliferation, induction of diﬀerentiationand apoptosis
[16]. It also induces G0/G1 arrest of the cell cycle and
apoptosis in the human hepatoma Hep G2 cell line [17].
Several indian medicinal mushrooms, such as Ganoderma
lucidum, Phellinus rimosus, Pleurotus ﬂorida and Pleurotus
pulmonarius, have shown strong antioxidant and anti-cancer
eﬀects [18]. The results of the present study suggest that CL,
POandVVmaybeusefulforintegrativeandcomplementary
medicine by promoting apoptotic cell death in human
colorectalcancercellsviainductionofROSproduction,GSH
depletion and mitochondrial dysfunction.
In the present study, the protein extracts of CL, PO
a n dV Vw e r eu s e dt oe v a l u a t ea n t i - c a n c e re ﬀects. The
protein extracts of PO and VV induced marked apoptosis
in SW480 cells (Figure 3). The apoptotic mechanism of the
PO protein extract in SW480 cells was partially related to
ROSproduction,GSHdepletionand ΔΨm loss(Figure 7(a)).
However,the apoptoticmechanism ofthe VVproteinextract
is not clear because NAC, GSH and CyA did not prevent
VV protein extract-induced apoptosis (Figure 7(b)). This
mechanism should be further studied in the future.
In 1963, related proteins and amino acids of PO were
studied [19]. The ﬁrst application of PO for antineo-
plastic activity utilized its polysaccharide [20]. Another
study demonstrated that PO expresses marked antihepatoma
and antisarcoma activities [21]. Treatment with the water
extract of PO (150μgmL −1) induced phosphatidyl serine
translocation from the inner membrane to the outer mem-
brane after as little as 2h and then induced apoptosis in
human prostate cancer PC-3 cells [6]. Recently, the water-
soluble polysaccharide extracted from the fruiting bodies
of PO was shown to have obvious antitumor activity; they
inhibited human HeLa cells in a concentration-dependentEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: GSH depletion analysis of PO and VV protein extract-treated SW480 cells. SW480 cells were exposed to PO and VV protein
extracts (100μgmL −1) for 24h. After treatment, the cells were incubated with 25μM CMF-DA for 30min in a 37
◦CC O 2 incubator and
ﬂuorescence was then measured with a ﬂow cytometer. Data in each panel represent the percentage of GSH-depleted cells with respect to the
total cells. The values shown are means ± SD (n = 5–8). ∗P<. 05 (signiﬁcantdiﬀerences from the untreated group).
manner [11]. The water-soluble polysaccharide extracted
from PO exhibited signiﬁcantly lower cytotoxicity in human
embryonic kidney 293T cells than in HeLa tumor cells when
compared with 5-Fu [11]. These results suggest that the
water-soluble polysaccharide extracted from PO may be a
potential candidate for the development of a novel low-
toxicity antitumor agent.
It is interesting that the protein extracts of VV had
a stronger apoptotic eﬀect than those of PO (Figure 3).
Despite the lack of clear understanding of the detailed
apoptoticmechanismoftheproteinextractsfromVV,several
other reports have observed anti-cancer eﬀects for VV. The
cold-alkali extracts and the polysaccharide of VV expressed
antitumor activity [22–24]. Another study demonstrated
that the lectin of VV exhibits immunomodulatory eﬀects,
stimulating the expression of Th1 cytokines and the prolif-
erative activity of mouse splenocytes [25]. The lectin of VV
also induces rapid expression of CD69, CD25, nuclear factor
ofactivated Tcells,IL-2andproliferatingcellnuclearantigen
in a concentration- and time-dependent manner, leading to
lymphocyte proliferation in a calcium-dependent manner
[26]. The VV lectin also arrested S180 mouse sarcoma cell
proliferation by blocking cell cycle progression in the G2/M
phase via activation of the expression of the cyclin kinase
inhibitors p21, p27, p53 and Rb [27].
The regulation ofapoptosis is related to the susceptibility
of cancer cells to chemotherapy. Many anticancer drugs can
slow the progression of leukemia and other cancers through
induction of apoptosis [28]. For this reason, apoptosis is
considered to be a very important event for the development
of anti-cancer drugs. The present results demonstrated that
the protein extracts of PO and VV not only induced apop-
tosis but also resulted in ROS production, GSH depletion
and ΔΨm loss. These phenomena are similar to eﬀects
observed for some clinical and pre-clinical anticancer drugs.
For example, cisplatin can change the intracellular ROS and
ΔΨm in human Hep G2 hepatoma cells [29]. Curcumin,
a pre-clinical anticancer drug, can increase ROS, induce
GSH depletion, decrease ΔΨm, release cytochrome c and
activate caspasestoinduceapoptosisincancercells[30].Our
previous study also demonstrated that the protein extracts
of CL-induced apoptosis in human colorectal SW480 cancer
cells through γ-glutamylcysteine synthase inhibition and
GSH depletion [2]. ROS production, GSH depletion and
ΔΨm loss are highly correlated with PO protein-extract-
induced apoptosis in SW480 cells. Pretreatment with NAC,
GSH and CyA did not aﬀect thefraction of cellsin theSubG1
phase after treatment with VV protein extracts; thus, the
m e c h a n i s mo fV V - i n d u c e da p o p t o s i si su n k n o w n .T h i si st h e
ﬁrst ﬁnding that the proteins of PO and VV extracted by8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: ΔΨm analysis of PO and VV protein extract-treated SW480 cells. SW480 cells were treated with PO and VV protein extracts
(100μgmL −1) for 24h. After treatment, the culture medium was replaced with a new medium containing 5μM rhodamine 123. Cultures
were then incubated for 20min in the dark. Values in each panel represent the rhodamine 123 ﬂuorescence intensity within the cells. The
values shown are means ± SD (n = 5–8). ∗P<. 05 (signiﬁcantdiﬀerences from the untreated group).
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Figure 7: Evaluation of the critical mechanism in PO and VV protein extract-induced apoptosis. (a) The SW480 cells were treated with
(a) PO and (b) VV protein extracts (0 (untreated) or 10μgmL −1) for 24h, pretreated with 10mM NAC, 10mM GSH or 5μMC y Af o r1h ,
followed by (a) PO and (b) VV protein extracts (10μgmL −1) treatment for 24h, and then analyzed for DNA damage. Data in each panel
show the percentages of cells in the SubG1 (DNA-damaged cells), G1,Sa n dG 2/M phases of cell cycle. These experiments were performed at
least three times and a representative experiment is presented.Evidence-Based Complementary and Alternative Medicine 9
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Figure 8: A hypothetical diagram for the anti-cancer eﬀect of CL,
PO and VV protein extracts.
ammonia sulfate show marked anti-cancer eﬀects in human
colorectal cancer cells and human monocytic leukemia cells.
A hypothetical diagram that illustrates the anti-cancer eﬀect
of CL, PO and VV protein extracts is depicted in Figure 8.
5.Conclusions
The protein extracts of PO induced ROS production, GSH
depletion and ΔΨm loss; these events were correlated with
apoptosis in SW480 cells. The protein extracts of CL, PO
and VV can be considered as a source of potential cancer
therapeutic agents.
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